February 20, 2018 07:23 AM EST

AbbVie steers past the wreckage, reserves $224M to kick off once-and-done gene therapy with Voyager to fight Alzheimer’s

AbbVie $ABBV is hitching a ride on the gene therapy tech platform at Voyager $VYGR to try a new approach to tackle Alzheimer’s.

The two …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Ab­b­Vie steers past the wreck­age, re­serves $224M to kick off once-and-done gene ther­a­py with Voy­ager to fight Alzheimer’s